{"acute febrile neutrophilic dermatosis": 28.75, "acute kidney injury": 2.0, "acute myeloid leukaemia": 82.11, "acute myeloid leukaemia recurrent": 322.06, "agranulocytosis": 10.94, "anaemia": 9.38, "bacteraemia": 18.2, "blast cell count increased": 55.66, "bone marrow failure": 12.41, "bronchopulmonary aspergillosis": 12.98, "cardiac disorder": 2.25, "cellulitis": 2.0, "covid-19 pneumonia": 3.53, "cytopenia": 73.5, "disease progression": 2.81, "disease recurrence": 2.81, "drug resistance": 2.02, "febrile neutropenia": 66.32, "full blood count decreased": 6.12, "fungal infection": 6.22, "granulocyte count decreased": 63.29, "haematotoxicity": 57.45, "haemoglobin decreased": 2.5, "haemophagocytic lymphohistiocytosis": 6.72, "hypokalaemia": 2.89, "hypoxia": 2.3, "infection": 8.06, "leukocytosis": 4.92, "leukopenia": 3.73, "minimal residual disease": 130.24, "multiple organ dysfunction syndrome": 3.34, "myelodysplastic syndrome": 17.07, "myelosuppression": 43.22, "neutropenia": 20.61, "neutropenic sepsis": 50.61, "neutrophil count decreased": 11.32, "off label use": 4.95, "pancytopenia": 14.42, "platelet count decreased": 6.64, "pneumocystis jirovecii pneumonia": 5.95, "pneumonia": 5.04, "pneumonia fungal": 35.72, "pneumonitis": 4.46, "product use in unapproved indication": 2.44, "product use issue": 2.34, "respiratory failure": 2.37, "sepsis": 6.83, "septic shock": 9.12, "splenomegaly": 4.37, "staphylococcal sepsis": 16.55, "therapeutic product effect incomplete": 5.05, "therapy non-responder": 2.0, "thrombocytopenia": 13.9, "treatment failure": 2.91, "tumour lysis syndrome": 80.21, "unevaluable event": 3.16, "white blood cell count abnormal": 14.76, "white blood cell count decreased": 8.63, "white blood cell count increased": 2.04}